Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
947studies shown
Showing 109-120 of 947
Other study type icon
RecruitingISRCTN58916738

The impact on wellbeing of HS2

This study is recruiting in the United Kingdom. It focuses on Mental health.

In United Kingdom
Mental healthOtherOver 18 Years
Countries
United Kingdom
Sponsor
RAND Europe
Condition
Mental health
Drug study icon
RecruitingNCT05511363

KarXT for Schizophrenia

This study is recruiting in the United States, in France, in the United Kingdom, .... It is testing KarXT for Schizophrenia.

In United Kingdom
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing KarXT for Schizophrenia.

In United Kingdom
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Other study type icon
RecruitingNCT06524830

VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression.

In United Kingdom
DepressionOtherFrom 18 Years to 65 Years
Countries
United States, Australia, Canada, ...
Sponsor
atai Therapeutics, Inc.
Condition
Depression
Drug study icon
RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Safety and Efficacy of KarXT + KarX-EC for Schizophrenia.

In United Kingdom
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, Australia, Canada, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Other study type icon
RecruitingNCT07300969

Effectiveness of DT-101 in depression

This study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing DT-101 for depression.

In United Kingdom
DepressionOtherFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Draig Therapeutics Ltd
Condition
Depression
Other study type icon
RecruitingISRCTN18346744

Safety study of NTX-1955 in anxiety

This study is recruiting in the United Kingdom. It is testing NTX-1955 for anxiety.

In United Kingdom
AnxietyOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Newleos Therapeutics
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.